These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 32682849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R, Yildiz N, Alkan H.
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
    Rai BP, Cody JD, Alhasso A, Stewart L.
    Cochrane Database Syst Rev; 2012 Dec 12; 12(12):CD003193. PubMed ID: 23235594
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M, Crampton J.
    Physiotherapy; 2019 Dec 12; 105(4):469-475. PubMed ID: 30862384
    [Abstract] [Full Text] [Related]

  • 10. Bladder training compared to bladder training associated with pelvic floor muscle training for overactive bladder symptoms in women: A randomized clinical trial.
    Monteiro S, Rocha AK, Valim L, Silva SLAD, Riccetto C, Botelho S.
    Neurourol Urodyn; 2023 Nov 12; 42(8):1802-1811. PubMed ID: 37723948
    [Abstract] [Full Text] [Related]

  • 11. The effects of pelvic floor muscle training combined with Kinesio taping on bladder symptoms, pelvic floor muscle strength, and quality of life in women with overactive bladder syndrome: A randomized sham-controlled trial.
    Toprak Celenay S, Korkut Z, Oskay K, Aydin A.
    Physiother Theory Pract; 2022 Feb 12; 38(2):266-275. PubMed ID: 32282255
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of the transcutaneous tibial nerve stimulation and pelvic floor muscle training with biofeedback in women with multiple sclerosis for the management of overactive bladder.
    Polat Dunya C, Tulek Z, Kürtüncü M, Panicker JN, Eraksoy M.
    Mult Scler; 2021 Apr 12; 27(4):621-629. PubMed ID: 32513049
    [Abstract] [Full Text] [Related]

  • 13. Evaluating the effects of transcutaneous tibial nerve stimulation or pelvic floor muscle training on sexual dysfunction in female multiple sclerosis patients reporting overactive bladder.
    Polat Dunya C, Tülek Z, Kürtüncü M, Gündüz T, Panicker JN, Eraksoy M.
    Neurourol Urodyn; 2021 Aug 12; 40(6):1661-1669. PubMed ID: 34174117
    [Abstract] [Full Text] [Related]

  • 14. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder.
    Iyer S, Laus K, Rugino A, Botros C, Lozo S, Botros SM, Goldberg R, Tomezsko J, Gafni-Kane A, Wroblewski K, Sand P.
    Int Urogynecol J; 2019 Aug 12; 30(8):1253-1259. PubMed ID: 30467763
    [Abstract] [Full Text] [Related]

  • 15. The effects of pelvic floor muscle therapy on symptoms, voiding, and pelvic floor muscle activity parameters in children with overactive bladder.
    Pekbay Y, Ergin O, Topuz B, Sarikaya S, Acar ZZ, Irkilata HC, Dayanç M.
    Neurourol Urodyn; 2019 Jun 12; 38(5):1430-1442. PubMed ID: 31006136
    [Abstract] [Full Text] [Related]

  • 16. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator.
    Kapur A, Aalami Harandi A, Hartman-Kenzler J, Kim J.
    Neurourol Urodyn; 2024 Apr 12; 43(4):959-966. PubMed ID: 38390786
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.
    Salatzki J, Liechti MD, Spanudakis E, Gonzales G, Baldwin J, Haslam C, Pakzad M, Panicker JN.
    BJU Int; 2019 May 12; 123(5A):E20-E28. PubMed ID: 30552801
    [Abstract] [Full Text] [Related]

  • 18. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L, Renson C, Van de Walle J, Everaert K, Spinoit AF.
    Trials; 2021 Apr 02; 22(1):247. PubMed ID: 33810804
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.
    Ayeleke RO, Hay-Smith EJ, Omar MI.
    Cochrane Database Syst Rev; 2013 Nov 20; (11):CD010551. PubMed ID: 24259154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.